Skip to content

Paula Anzenberg

NPI 1730829334ActiveIndividual· Internal Medicine, Cardiovascular Disease· Hartford, CT

Internal Medicine, Cardiovascular Disease in Hartford, Connecticut, licensed in CT, with an NPI issued in March 2022. Part D covered 99 prescriptions written in 2024, 98% of them generic. Abbott Laboratories was the largest of 5 companies reporting payments in 2025, $369.88 in all, mostly food and beverage.

Overview

NPI1730829334
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 31, 2022
Last updated in NPPESJul 10, 2025
Certified by providerJul 10, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (MA)

Part D prescriptions in 2024

Prescriptions (claims)99 · 124 30-day fills
Patients35
Total drug cost$3,519
Generic share98% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$369.88 · 8 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$369.88 · 8 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Hartford

All Internal Medicine, Cardiovascular Disease providers in Connecticut →